
Strolll
Strolll develops Digital Therapeutics software for Augmented Reality (AR) glasses that empower movement therapy for people with neurological disorders.
Date | Investors | Amount | Round |
---|---|---|---|
- | investor investor investor | €0.0 | round |
investor | €0.0 | round | |
investor | €0.0 | round | |
investor investor | €0.0 | round | |
investor | €0.0 | round | |
investor | €0.0 | round | |
* | £10.4m | Series A | |
Total Funding | 000k |
Related Content
Strolll is a pioneering startup dedicated to transforming the daily lives of individuals with Parkinson's Disease. Founded in 2018 by Tom Finn, the company emerged from a personal experience when Tom noticed the significant improvement in his father's walking ability, who suffers from Vascular Dementia, through the use of colored lines during physiotherapy. This inspired Tom to create innovative solutions for neurological disorders.
Strolll's flagship product, Cue X, is a wearable physical therapy device designed to enhance walking gait and balance for people with Parkinson's Disease. Cue X delivers sensory cues—visual, audio, and haptic (touch-based)—to help users maintain better control over their movements. The device offers over 100 customizable cue variations, allowing it to be tailored to each individual's specific needs and preferences.
The company operates in the healthcare and medical devices market, focusing on neurological disorders. Strolll serves a diverse range of clients, including individuals with Parkinson's Disease, their families, caregivers, physiotherapists, doctors, neurologists, health insurers, patient advocacy groups, scientists, and universities. By fostering collaboration among these stakeholders, Strolll aims to accelerate the development and adoption of practical solutions that can significantly improve the quality of life for millions of people worldwide.
Strolll's business model revolves around the sale of its Cue X device. Revenue is generated through direct sales to consumers, partnerships with healthcare providers, and collaborations with insurance companies that may cover the cost of the device for patients. The company also engages in research and development to continually enhance its product offerings and maintain its position as a leader in the field of neurological disorder treatment.
Keywords: Parkinson's Disease, wearable device, physical therapy, sensory cues, neurological disorders, healthcare, Cue X, personalized therapy, innovation, collaboration.